Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative MindCare is a private U.S. mental health clinic operator in the Chicago area that appears to have originated as "Innovative Ketamine," an IV ketamine infusion practice founded by Dr. Rahul Khare. The business focuses on commercially delivered ketamine-based treatment services for depression, anxiety, PTSD, OCD, bipolar disorder, chronic pain, and related conditions rather than on discovery-stage drug development. Publicly available profiles indicate the clinic began treating patients with IV ketamine around 2018-2019 and later expanded beyond its original Chicago Lakeview location to Downers Grove. The company now markets under the Innovative MindCare and Innovative Psychedelics branding, with ketamine infusion therapy as a core offering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Ketamine.